Möchten Sie immer auf dem neuesten Stand bleiben?

WARREN, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address...

Pune, India, March 05, 2021 (GLOBE NEWSWIRE) -- The global Immune Health Supplements Market is likely to grow astonishingly backed by the increasing popularity of non-GMO and organic ingredients...

-Yselty® for uterine fibroids: US New Drug Application filing planned in Q2:21; European marketing approval anticipated in Q4:21- -Yselty® for endometriosis: Readout from Phase 3 EDELWEISS 3...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- Global Care Capital Inc....

Vancouver, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- The global research antibodies market is projected to acquire up to USD 5,325.8 Million by 2027, registering a CAGR of 5.9% over the...

NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that results of the ULTIMATE I & II Phase 3 trials evaluating ublituximab, the Company’s novel,...

LEXINGTON, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the fourth...

CHARLOTTESVILLE, Va., March 04, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...

Companies will combine their unique scientific and technical expertise to develop a first-in-class anti-SIRPα antibody conjugated to TLR9 agonist (“SIRPα TRAAC”) that delivers targeted immune...

Company will not pursue additional development of APL-9 for the treatment of severe COVID-19Interim review by independent data monitoring committee (DMC) found no meaningful reduction in the overall...